The Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol in the Treatment of COPD in the Elderly

Polimorfismos en el gen FRMD4A se asocian a riesgo de enfermedad pulmonar obstructiva crónica en población latinoamericana

(2022) Roberto Díaz-Peña et al.   ARCHIVOS DE BRONCONEUMOLOGIA

Angiotensin-converting enzyme 2 in peripheral lung club cells modulates the susceptibility to SARS-CoV-2 in chronic obstructive pulmonary disease

(2022) Yang Peng et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Impaired Ventilatory Efficiency, Dyspnea and Exercise Intolerance in Chronic Obstructive Pulmonary Disease: Results from the CanCOLD Study

(2022) Devin B. Phillips et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Comparation of predictive value of CAT and change in CAT in the short term for future exacerbation of chronic obstructive pulmonary disease

(2022) Ling Lin et al.   ANNALS OF MEDICINE

Letter to the editor regarding "effect of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis"

(2022) Hui Wang et al.   ANNALS OF MEDICINE

Protective effect of total Saponins from American ginseng against cigarette smoke-induced COPD in mice based on integrated metabolomics and network pharmacology

(2022) Hongqiang Lin et al.   BIOMEDICINE & PHARMACOTHERAPY

Chronic obstructive pulmonary disease and atherosclerosis: common mechanisms and novel therapeutics

(2022) Kurt Brassington et al.   CLINICAL SCIENCE

Effects of Vitamin D on Respiratory Function and Immune Status for Patients with Chronic Obstructive Pulmonary Disease (COPD): A Systematic Review and Meta-Analysis

(2022) Huan Yang et al.   Computational and Mathematical Methods in Medicine

Empagliflozin in patients with type 2 diabetes mellitus and chronic obstructive pulmonary disease

(2022) Stefan D. Anker et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Clinician Perspectives on How to Hold Earlier Discussions About Palliative and End-of-Life Care With Chronic Obstructive Pulmonary Disease Patients

(2022) Nuno Tavares et al.   Journal of Hospice & Palliative Nursing

Diagnostic value of pulmonary ultrasound in acute exacerbation of chronic obstructive pulmonary disease: A pilot study

(2022) Hong Li et al.   MEDICINA CLINICA

Evidence-based management approaches for patients with severe chronic obstructive pulmonary disease (COPD): A practice review

(2022) Yu Fu et al.   PALLIATIVE MEDICINE

Cardiovascular events and all‐cause mortality in patients with chronic obstructive pulmonary disease using olodaterol and other long‐acting beta2‐agonists

(2022) Cristina Rebordosa et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Common exacerbation-prone phenotypes across asthma and chronic obstructive pulmonary disease (COPD)

(2022) Kentaro Hyodo et al.   PLoS One

Survival in COPD patients treated with bronchoscopic lung volume reduction

(2022) Jorine E. Hartman et al.   RESPIRATORY MEDICINE

Use of a Wearable Biosensor to Study Heart Rate Variability in Chronic Obstructive Pulmonary Disease and Its Relationship to Disease Severity

(2022) Seon-Cheol Park et al.   SENSORS

Chronic obstructive pulmonary disease and influenza vaccination effect in preventing outpatient and inpatient influenza cases

(2022) Iván Martínez-Baz et al.   Scientific Reports

Association Between Vitamin D Level and Respiratory Symptoms in Patients with Stable Chronic Obstructive Pulmonary Disease

(2022) Chai Young Lee et al.   International Journal of Chronic Obstructive Pulmonary Disease

Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial

(2022) Ahmed J Yousuf et al.   Lancet Respiratory Medicine

Prediction of Chronic Obstructive Pulmonary Disease Exacerbation Events by Using Patient Self-reported Data in a Digital Health App: Statistical Evaluation and Machine Learning Approach

(2022) Francis P Chmiel et al.   JMIR Medical Informatics

Respiratory Muscle Training Can Improve Cognition, Lung Function, and Diaphragmatic Thickness Fraction in Male and Non-Obese Patients with Chronic Obstructive Pulmonary Disease: A Prospective Study

(2022) Yuan-Yang Cheng et al.   Journal of Personalized Medicine

Static and Dynamic Postural Characteristics in Patients with Chronic Obstructive Pulmonary Disease: The Relationship with Dyspnea and Pulmonary Functions

(2022) Ilknur Naz et al.   HEART & LUNG

Indacaterol/Glycopyrronium/Mometasone: A Review in Asthma

(2021) Hannah A. Blair   DRUGS

Tratamiento de inicio en la enfermedad pulmonar obstructiva crónica, según GesEPOC 2021 vs. GesEPOC 2017, ¿acercando criterios con GOLD 2021?

(2021) Juan Marco Figueira Gonçalves et al.   ARCHIVOS DE BRONCONEUMOLOGIA

Budesonide/Glycopyrronium/Formoterol: A Review in COPD

(2021) Young-A Heo   DRUGS

Benefits of budesonide/glycopyrrolate/formoterol fumarate (BGF) on symptoms and quality of life in patients with COPD in the ETHOS trial

(2021) Fernando J. Martinez et al.   RESPIRATORY MEDICINE

Aclidinium bromide/formoterol fumarate as a treatment for COPD: an update

(2021) Anthony D. D’Urzo et al.   Expert Review of Respiratory Medicine

T2 Biomarkers as Predictors of Exacerbations of Chronic Obstructive Pulmonary Disease

(2021) Bernardino Alcázar-Navarrete et al.   ARCHIVOS DE BRONCONEUMOLOGIA

Fractional Exhaled Nitric Oxide Guided-Therapy in Chronic Obstructive Pulmonary Disease: A Stratified, Randomized, Controlled Trial

(2021) Kang-Cheng Su et al.   ARCHIVOS DE BRONCONEUMOLOGIA

Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler in Chinese Patients with COPD: A Subgroup Analysis of KRONOS

(2020) Chen Wang et al.   ADVANCES IN THERAPY

Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist (ICS/LAMA/LABA) Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis

(2020) Gary T. Ferguson et al.   ADVANCES IN THERAPY

Glycopyrrolate and formoterol fumarate for the treatment of COPD

(2020) Pierre-Edouard Grillet et al.   Expert Review of Respiratory Medicine

Effect of a single day of increased as-needed budesonide–formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 study

(2020) Paul M O'Byrne et al.   Lancet Respiratory Medicine

Glycopyrronium/Formoterol: A Review in COPD

(2019) Zaina T. Al-Salama et al.   DRUGS

A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol

(2019) Klaus F. Rabe et al.   RESPIRATORY MEDICINE

Long-Term Safety and Efficacy of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD

(2019) Masakazu Ichinose et al.   International Journal of Chronic Obstructive Pulmonary Disease

Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD: A Subgroup Analysis of the KRONOS Study

(2019) Masakazu Ichinose et al.   International Journal of Chronic Obstructive Pulmonary Disease

The pharmacokinetics of three doses of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler compared with active controls: A Phase I randomized, single-dose, crossover study in healthy adults

(2018) Patrick Darken et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Clinicalpathological and prognostic significance of survivin expression in renal cell carcinoma: a meta-analysis

(2017) Zhichen Pu et al.   Oncotarget

Budesonide Multi-matrix for the Treatment of Patients with Ulcerative Colitis

(2015) Gary R. Lichtenstein   DIGESTIVE DISEASES AND SCIENCES